Aykut Soyder
Overview
Explore the profile of Aykut Soyder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cabioglu N, Karanlik H, Igci A, Muslumanoglu M, Gulcelik M, Uras C, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 39964563
No abstract available.
2.
Cabioglu N, Kocer H, Karanlik H, Gulcelik M, Igci A, Muslumanoglu M, et al.
JAMA Surg
. 2025 Jan;
160(3):257-266.
PMID: 39745737
Importance: Increasing evidence supports the oncologic safety of de-escalating axillary surgery for patients with breast cancer after neoadjuvant chemotherapy (NAC). Objective: To evaluate the oncologic outcomes of de-escalating axillary surgery...
3.
Cabioglu N, Karanlik H, Igci A, Muslumanoglu M, Gulcelik M, Uras C, et al.
Ann Surg Oncol
. 2024 Dec;
32(2):952-966.
PMID: 39623189
Background: This study aims to identify factors predicting recurrence and unfavorable prognosis in cN+ patients who have undergone sentinel lymph node biopsy (SLNB) following neoadjuvant chemotherapy (NAC). Methods: The retrospective...
4.
Muslumanoglu M, Cabioglu N, Igci A, Karanlik H, Kocer H, Senol K, et al.
Cancer
. 2024 Oct;
131(1):e35610.
PMID: 39476303
Background: The omission of axillary lymph node dissection (ALND) remains controversial for patients with residual axillary disease after neoadjuvant chemotherapy (NAC), regardless of the residual burden. This study evaluated the...
5.
Isiklar A, Aliyeva L, Yesilyurt A, Soyder A, Basaran G
Breast Cancer Res Treat
. 2023 Aug;
202(2):297-304.
PMID: 37615792
Purpose: One of the most important risk factors for hereditary breast and ovarian cancer is young age. We aim to report the frequency of pathogenic/likely pathogenic variants in breast cancer...
6.
Civan Kus C, Guldogan N, Yilmaz E, Soyder A, Arslan A, Aribal M
J Comput Assist Tomogr
. 2023 Mar;
47(4):561-568.
PMID: 36944155
Methods: A retrospective analysis was conducted on 75 lesions in 50 patients with pathologically proven breast cancer who underwent MRI in prone and supine positions between December 2019 and December...
7.
Soyder A, Guldogan N, Isiklar A, Aribal E, Basaran G
Breast Care (Basel)
. 2022 May;
55:1-6.
PMID: 35528628
Introduction: The COVID-19 pandemic has a worldwide negative impact on healthcare systems. This study aims to determine how the diagnosis, clinicopathological features, and treatment approaches of patients with breast cancer...
8.
Ozcinar B, Oner G, Makay O, Soyder A, Canturk N, Ugurlu M, et al.
Asian J Surg
. 2021 Aug;
45(1):407-411.
PMID: 34353709
Background: Primary hyperparathyroidism (pHPT) caused by a single benign parathyroid adenoma is a common endocrine disorder that is affected by regional differences. Living in different geographical regions reveals differences in...
9.
Guldogan N, Soyder A, Yilmaz E, Arslan A
Curr Med Imaging
. 2021 Aug;
18(1):99-102.
PMID: 34342259
Introduction: True thymic hyperplasia following chemotherapy has been described mostly in children. There are a few cases of thymus hyperplasia that have been reported in breast cancer patients. Diagnosis of...
10.
Isiklar A, Deniz C, Soyder A, Guldogan N, Yilmaz E, Basaran G
Eur J Breast Health
. 2021 Jul;
17(3):253-257.
PMID: 34263153
Objective: Coronavirus disease 2019 (COVID-19) has placed an unprecedented burden on healthcare systems and restricted resources for non-COVID patients worldwide. Treatment approaches and follow-up plans have been modified to prevent...